First extended-release corticosteroid injection for knee OA gets FDA approval


eMediNexus    10 October 2017

The US Food and Drug Administration FDA has approved triamcinolone acetonide extended release injectable suspension Zilretta to relieve pain of knee osteoarthritis. The drug is to be administered as an intra articular injection.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.